Prosthetic arteriovenous grafts for hemodialysis

Journal of Vascular Access

Volumn 10, Issue 3, 2009, Pages 137-147

  Akoh, Jacob A ^a  

^a DERRIFORD HOSPITAL   (United Kingdom)

Author keywords

Cumulative patency; Graft infection; Polytetrafluoroethylene (PTFE); Prosthetic grafts; Thrombosis

Indexed keywords

ANTIBIOTIC AGENT; CLOPIDOGREL; FIBRINOLYTIC AGENT; POLITEF; WARFARIN;

ANASTOMOSIS; ANTIBIOTIC PROPHYLAXIS; ARTERY BLOOD FLOW; ARTERY STEAL SYNDROME; BLEEDING; BLOOD VESSEL GRAFT; DACRON VASCULAR PROSTHESIS; FALSE ANEURYSM; GRAFT INFECTION; GRAFT OCCLUSION; GRAFT PATENCY; HEMODIALYSIS PATIENT; HUMAN; INFECTION RISK; LIMB SWELLING; MECHANICAL THROMBECTOMY; NEUROPATHY; PORTAL HYPERTENSION; PROSTHETIC ARTEROIVENOUS GRAFT; REVIEW; SURGICAL TECHNIQUE; THROMBOSIS; TREATMENT RESPONSE; VASCULAR ACCESS; ARTERIOVENOUS SHUNT; BLOOD VESSEL PROSTHESIS; BLOOD VESSEL TRANSPLANTATION; INFECTION; INSTRUMENTATION; ISCHEMIA; PATHOPHYSIOLOGY; PATIENT SELECTION; PROSTHESIS; RENAL REPLACEMENT THERAPY; RISK ASSESSMENT; STENOSIS, OCCLUSION AND OBSTRUCTION; TIME; TREATMENT OUTCOME; VASCULAR PATENCY;

ARTERIOVENOUS SHUNT, SURGICAL; BLOOD VESSEL PROSTHESIS; BLOOD VESSEL PROSTHESIS IMPLANTATION; CONSTRICTION, PATHOLOGIC; GRAFT OCCLUSION, VASCULAR; HUMANS; ISCHEMIA; PATIENT SELECTION; PROSTHESIS DESIGN; PROSTHESIS-RELATED INFECTIONS; RENAL DIALYSIS; RISK ASSESSMENT; THROMBOSIS; TIME FACTORS; TREATMENT OUTCOME; VASCULAR PATENCY;

EID: 70350738252     PISSN: 11297298     EISSN: None     Source Type: Journal    
DOI: 10.1177/112972980901000301     Document Type: Review

References (101)

1. Enzler MA, Rajmon T, Lachat M, Largiader F. Long-term function of vascular access for haemodialysis. Clin Transplant 1996; 10: 511-5.
2. Coburn MC, Carney WI, Jr. Comparison of basilic vein and polytetrafluoroethylene for brachial arteriovenous fistula. J Vasc Surg 1994; 20: 896-902.
3. Gibson KD, Caps MT, Kohler TR, et al. Assessment of policy to reduce placement of prosthetic hemodialysis access. Kidney Int 2001; 59: 2335-45.
4. Mosquera D. Vascular access survival and incidence of revisions: a comparison of prosthetic grafts, simple autogenous fistulas, and venous transposition fistulas from the United States Renal Data System Dialysis Morbidity and Mortality Study. J Vasc Surg 2003; 37: 238-9.
5. Kapoian T, Sherman RA. A brief history of vascular access for hemodialysis: an unfinished story. Semin Nephrol 1997; 17: 239-45.
6. Hirth RA, Turenne MN, Woods JD, et al. Predictors of type of vascular access in hemodialysis patients. JAMA 1996; 276: 1303-8.
7. Nguyen VD, Lawson L, Ledeen M, et al. Successful multidisciplinary interventions for arteriovenous fistula creation by the Pacific Northwest Renal Network 16 Vascular access quality improvement program. J Vasc Access 2007; 8: 3-11.
8. Strott KL, Rodgers DJ, Karp SK, Woodruff SD, Wright LD. Increasing the use of arteriovenous fistulas (AVF): a network QI project. Nephrol News Issues 2004; 18: 49-53.
9. Glazer S, Diesto J, Crooks P, et al. Going beyond the kidney disease outcome quality initiative: hemodialysis access experience at Kaiser Permanente Southern California. Ann Vasc Surg 2006; 20: 75-82.
10. Dember LM, Beck GJ, Allon M, et al. Effect of Clopidogrel on early failure of arteriovenous fistulas for hemodialysis: a randomized controlled trial. JAMA 2008; 299: 2164-71.
11. Won T, Min SK, Jang JW, et al. Early result of arteriovenous graft with deep forearm veins as an outflow in hemodialysis patients. Ann Vasc Surg 2002; 16: 501-4.
12. Fan PY, Schwab SJ. Vascular access: concepts for the 1990s. J Am Soc Nephrol 1992; 3: 1-11.
13. Applebaum H, Shashikumar VL, Somers LA, et al. Improved hemodialysis access in children. J Pediatr Surg 1980; 15: 764-9.
14. Davidson I, Gallieni M, Saxena R, Dolmatch B. A patient centred decision making dialysis access algorythm. J Vasc Access 2007; 8: 59-68.
15. Baraldi A, Manenti A, Di Felice A, et al. Absence of rejection in cryopreserved saphenous vein allografts for hemodialysis. ASAIO Trans 1989; 35: 196-9.
16. Bolton WD, Cull DL, Taylor SM, et al. The use of cryopreserved femoral vein grafts for hemodialysis access in patients at high risk for infection: a word of caution. J Vasc Surg 2002; 36: 464-8.
17. Katzman HE, Glickman MH, Schild AF, Fujitani RM, Lawson JH. Multicentre evaluation of the bovine mesenteric vein bioprostheses for hemodialysis access in patients with an earlier failed prosthetic graft. J Am Coll Surg 2005; 201: 223-30.
18. Glickman MH, Lawson JH, Katzman HE, Schild AF, Fujitani RM. Challenges of hemodialysis access for high risk patients: impact of mesenteric vein bioprosthetic graft. J Vasc Access 2003; 4: 73-80.
19. Darby CR, Roy D, Deardon D, Cornall A. Depopulated bovine ureteric xenograft for complex haemodialysis vascular access. Eur J Vasc Endovasc Surg 2006; 32: 181-6.
20. Raju S. PTFE grafts for hemodialysis access: techniques for insertion and management of complications. Ann Surg 1987; 206: 666-73.
21. Tordoir JH, Hofstra L, Leunissen KM, Kitslaar PJ. Early experience with stretch polytetrafluoroethylene grafts for haemodialysis access surgery: results of a prospective randomised study. Eur J Vasc Endovasc Surg 1995; 9: 305-9.
22. Almonacid PJ, Pallares EC, Rodriguez AQ, Valdes JS, Rueda Orgaz JA, Polo JR. Comparative study of use of Diastat versus standard wall PTFE grafts in upper arm hemodialysis access. Ann Vasc Surg 2000; 14: 659-62.
23. Coyne DW, Lowell JA, Windus DW, et al. Comparison of survival of an expanded polytetrafluoroethylene graft designed for early cannulation to standard wall polytetrafluoroethylene grafts. J Am Coll Surg 1996; 183: 401-5.
24. Gross GF, Hayes JF. PTFE graft arteriovenous fistulae for hemodialysis access. Am Surg 1979; 45: 748-9.
25. Bacchini G, Del Vecchio L, Andrulli S, Pontoriero G, Locatelli F. Survival of prosthetic grafts of different materials after impairment of a native arteriovenous fistula in hemodialysis patients. ASAIO J 2001; 47: 30-3.
26. Peng CW, Tan SG. Polyurethane grafts: a viable alternative for dialysis arteriovenous access? Asian Cardiovasc Thorac Ann 2003; 11: 314-8.
27. Kakkos SK, Haddad R, Haddad GK, et al. Results of aggressive graft surveillance and endovascular treatment on secondary patency rates of Vectra Vascular Access grafts. J Vasc Surg 2007; 45: 974-80.
28. Silva MB Jr, Hobson RW 2nd, Pappas PJ, et al. A strategy for increasing use of autogenous hemodialysis access procedures: impact of preoperative noninvasive evaluation. J Vasc Surg 1998; 27: 302-7.
29. Robbin ML, Gallichio MH, Deierhoi MH, Young CJ, Weber TM, Allon M. US vascular mapping before hemodialysis access placement. Radiology 2000; 217: 83-8.
30. Malovrh M. Non-invasive evaluation of vessels by duplex sonography prior to construction of arteriovenous fistulas for haemodialysis. Nephrol Dial Transplant 1998; 13: 125-9.
31. Khadra MH, Dwyer AJ, Thompson JF. Advantages of polytetrafluoroethylene arteriovenous loops in the thigh for hemodialysis access. Am J Surg 1997; 173: 280-3.
32. Tashjian DB, Lipkowitz GS, Madden RL, et al. Safety and efficacy of femoral-based hemodialysis access grafts. J Vasc Surg 2002; 35: 691-3.
33. Salimi J. Patency rate and complications of vascular access grafts for hemodialysis in lower extremities. Saudi J Kidney Dis Transpl 2008; 19: 929-32.
34. Slater ND, Raftery AT. An evaluation of expanded polytetrafluoroethylene (PTFE) loop grafts in the thigh as vascular access for haemodialysis in patients with access problems. Ann R Coll Surg Engl 1988; 70: 243-5.
35. Englesbe MJ, Al-Holou WN, Moyer AT, et al. Single centre review of femoral arteriovenous grafts for hemodialysis. World J Surg 2006; 30: 171-5.
36. Scott JD, Cull DL, Kalbaugh CA, et al. The mid-thigh loop arteriovenous graft: patient selection, technique, and results. Am Surg 2006; 72: 825-8.
37. Rizzuti RP, Hale JC, Burkart TE. Extended patency of expanded polytetrafluoroethylene grafts for vascular access using optimal configuration and revisions. Surg Gynecol Obstet 1988; 166: 23-7.
38. Jean-Baptiste E, Hassen-Khodja R, Haudebourg P, Decklemy S, Batt M, Bouillanne PJ. Axillary loop grafts for hemodialysis access: midterm results from a single-centre study. J Vasc Surg 2008; 47: 138-43.
39. Chemla ES, Morsy M, Anderson L, Makanjuola D. Complex bypasses and fistulas for difficult hemodialysis access: a prospective, single centre experience. Semin Dial 2006; 19: 246-50.
40. Sullivan KL, Besarab A, Bonn J, Shapiro MJ, Gardiner GA Jr, Moritz MJ. Hemodynamics of failing dialysis grafts. Radiology 1993; 186: 867-2.
41. Polo JR, Ligero JM, Diaz-Cartelle J, Garcia-Pajares R, Cervera T, Reparaz L. Randomized comparison of 6-mm straight grafts versus 6- to 8-mm tapered grafts for brachial-axillary dialysis access. J Vasc Surg 2004; 40: 319-24.
42. Hakaim AG, Scott TE. Durability of early prosthetic dialysis graft cannulation: results of a prospective, non-randomized clinical trial. J Vasc Surg 1997; 25: 1002-5.
43. Goldstein LJ, Helfend LK, Kordestani RK. Postoperative oedema after vascular access causing nerve compression secondary to the presence of a perineuronal lipoma: case report. Neurosurgery 2002; 50: 412-3.
44. Hofstra L, Tordoir JH, Kitslaar PJ, Hoeks AP, Daemen MJ. Enhanced cellular proliferation in intact stenotic lesions derived from human arteriovenous fistulas and peripheral bypass grafts. Does it correlate with flow parameters? Circulation 1996; 94: 1283-90.
45. Loth F, Jones SA, Zarins CK, et al. Relative contribution of wall shear stress and injury in experimental intimal thickening at PTFE end-to-side arterial anastomoses. J Biomech Eng 2002; 124: 44-51.
46. Bell DD, Rosental JJ. Arteriovenous graft life in chronic haemodialysis. A need for prolongation. Arch Surg 1988; 123: 1169-72.
47. Fillinger MF, Reinitz ER, Schwartz RA, et al. Graft geometry and venous intimal-medial hyperplasia in arteriovenous loop grafts. J Vasc Surg 1990; 11: 556-66.
48. Fisher RK, How TV, Toonder IM, et al. Harnessing haemodynamic forces for the suppression of anastomotic intimal hyperplasia: the rational for precuffed grafts. Eur J Vasc Endovasc Surg 2001; 21: 520-8.
49. Kissin M, Kansal N, Pappas PJ, DeFouw DO, Duran WN, Hobson RW, 2nd. Vein interposition cuffs decrease the intimal hyperplastic response of polytetrafluoroethylene bypass grafts. J Vasc Surg 2000; 31: 69-83.
50. Staalsen NH, Ulrich M, Winther J, Pedersen EM, How T, Nygaard H. The anastomosis angle does change the flow fields at vascular end-to-side anastomoses in vivo. J Vasc Surg 1995; 21: 460-71.
51. Kaufman JS, Fiore L, Hasbargen JA, O'Connor TZ, Perdriset G. A pharmacodynamic study of Clopidogrel in chronic haemodialysis patients. J Thromb Thrombolysis 2000; 10: 127-31.
52. Crowther MA, Clase CM, Margetts PJ, et al. Low-intensity warfarin is ineffective for the prevention of PTFE graft failure in patients on hemodialysis: a randomized controlled trial. J Am Soc Nephrol 2002; 13: 2331-7.
53. Schuman E, Quinn S, Standage B, Gross G. Thrombolysis versus thrombectomy for occluded hemodialysis grafts. Am J Surg 1994; 167: 473-6.
54. Marston WA, Criado E, Jaques PF, Mauro MA, Burnham SJ, Keagy BA. Prospective randomized comparison of surgical versus endovascular management of thrombosed dialysis access grafts. J Vasc Surg 1997; 26: 373-80.
55. Dougherty MJ, Calligaro KD, Schindler N, Raviola CA, Ntoso A. Endovascular versus surgical treatment for thrombosed hemodialysis grafts: a prospective, randomized study. J Vasc Surg 1999; 32: 1016-23.
56. Green LD, Lee DS, Kucey DS. A metaanalysis comparing surgical thrombectomy, mechanical thrombectomy, and pharmacomechanical thrombolysis for thrombosed dialysis grafts. J Vasc Surg 2002; 36: 939-45.
57. Beathard GA. Thrombolysis versus surgery for the treatment of thrombosed dialysis access grafts. J Am Soc Nephrol 1995; 6: 1619-24.
58. Uflacker R, Rajagopalan PR, Vujic I, Stutley JE. Treatment of thrombosed dialysis access grafts: randomised trial of surgical thrombectomy versus mechanical thrombectomy with the Amplatz device. J Vasc Interv Radio 1996; 7: 185-92.
59. Valji K, Bookstein JJ, Roberts AC, Davis GB. Pharmacomechanical thrombolysis and angioplasty in the management of clotted hemodialysis grafts: early and late clinical results. Radiology 1991; 178: 243-7.
60. Beathard GA, Welch BR, Maidment HJ. Mechanical thrombolysis for the treatment of thrombosed hemodialysis access grafts. Radiology 1996; 200: 711-6.
61. Andriani M, Drago G, Bernardi AM, et al. Recombinant tissue plasminogen activator (rt-PA) as first line therapy for declotting of haemodialysis access. Nephrol Dial Transplant 1995; 10: 1714-9.
62. Kakkos SK, Haddad GK, Haddad JA, Scully MM. Secondary patency of thrombosed prosthetic vascular access grafts with aggressive surveillance, monitoring and endovascular management. Eur J Endovasc Surg 2008; 36: 356-65.
63. Polak JF, Berger MF, Pagan-Marin H, Aruny JE, Meyerovitz MF. Comparative efficacy of pulse-spray thrombolysis and angioplasty versus surgical salvage procedures for treatment of recurrent occlusion of PTFE dialysis access grafts. Cardiovasc Intervent Radiol 1998; 21: 314-8.
64. Maya ID, Allon M. Outcomes of thrombosed arteriovenous grafts: comparison of stents vs angioplasty. Kidney Int 2006; 69: 934-7.
65. Gelbfish GA. Surgical versus percutaneous care of arteriovenous access. Semin Vasc Surg 2007; 20: 167-74.
66. Maya ID, Smith T, Young CJ, Allon M. Is surgical salvage of arteriovenous grafts feasible after unsuccessful percutaneous mechanical thrombectomy? Semin Dial 2008; 21: 174-7.
67. Fong IW, Capella JM, Simbul M, Angel J. Infection of arteriovenous fistulas created for chronic haemodialysis. Scand J Infect Dis 1993; 25: 215-20.
68. Churchill DN, Taylor DW, Cook RJ, et al. Canadian hemodialysis morbidity study. Am J Kidney Dis 1992; 19: 214-34.
69. Ryan SV, Calligaro KD, Scharff J, Dougherty MJ. Management of infected prosthetic dialysis arteriovenous grafts. J Vasc Surg 2004; 39: 73-8.
70. Schild AF, Simon S, Prieto J, Raines J. Single-center review of infections associated with 1574 consecutive vascular access procedures. Vasc Endovasc Surg 2003; 37: 27-31.
71. Taylor SM, Eaves GL, Weatherford DA, McAlhany JC Jr, Russell HE, Langan EM 3rd. Results and complications of arteriovenous access dialysis grafts in the lower extremity: a five year review. Am Surg 1996; 62: 188-91.
72. Nassar GM, Ayus JC. Infectious complications of the hemodialysis access. Kidney Int 2001; 60: 1-13.
73. Cull JD, Cull DL, Taylor SM, et al. Prosthetic thigh arteriovenous access: outcome with SVS/AAVS reporting standards. J Vasc Surg 2004; 39: 381-6.
74. Schutte WP, Helmer SD, Salazar L, Smith JL. Surgical treatment of infected prosthetic dialysis arteriovenous grafts: total versus partial graft excision. Am J Surg 2007; 193: 385-8.
75. Yu VL, Goetz A, Wagener M, et al. Staphylococcus aureus nasal carriage and infection in patients on hemodialysis. Efficacy of antibiotic prophylaxis. N Engl J Med 1986; 315: 91-6.
76. Matsuura JH, Rosenthal D, Wellons ED, Castronovo CS, Fronk D. Haemodialysis graft infections treated with cryopreserved femoral vein. Cardiovasc Surg 2002; 10: 561-5.
77. Taylor B, Sigley RD, May KJ. Fate of infected and eroded hemodialysis grafts and autogenous fistulas. Am J Surg 1993; 165: 632-6.
78. Schanzer A, Ciaranello AL, Schanzer H. Brachial artery ligation with total graft excision is a safe and effective approach to prosthetic arteriovenous graft infections. J Vasc Surg 2008; 48: 655-8.
79. Malik J, Tuka V, Kasalova Z, et al. Understanding the dialysis access steal syndrome. A review of the etiologies, diagnosis, prevention and treatment strategies. J Vasc Access 2008; 9: 155-66.
80. Berman SS, Gentile AT, Glickman MH, et al. Distal revascularization-interval ligation for limb salvage and maintenance of dialysis access in ischemic steal syndrome. J Vasc Surg 1997; 26: 393-404.
81. Schanzer H, Skladany M, Haimov M. Treatment of angioaccess-induced ischemia by revascularization. J Vasc Surg 1992; 16: 861-4.
82. Sessa C, Pecher M, Maurizi-Balzan J, et al. Critical hand ischaemia after angioaccess surgery: diagnosis and treatment. Ann Vasc Surg 2000; 14: 583-93.
83. Jean-Baptiste RS, Gahtan V. Distal revascularisation-interval ligation (DRIL) procedure for ischaemic steal syndrome (ISS) after arteriovenous fistula placement. Surg Technol Int 2004; 12: 201-5.
84. Tellioglu G, Berber I, Kilicoglu G, Seymen P, Kara M, Titz I. Doppler ultrasonography-guided surgery for high-flow hemodialysis vascular access: preliminary results. Transplant Proc 2008; 40: 87-9.
85. Murray BM, Rajczak S, Herman A, Leary D. Effect of surgical banding of a high-flow fistula on access flow and cardiac output: intraoperative and long-term measurements. Am J Kidney Dis 2004; 44: 1090-6.
86. Knox RC, Berman SS, Hughes JD, Gentile AT, Mills JL. Distal revascularization-interval ligation: a durable and effective treatment for ischaemic steal syndrome after hemodialysis access. J Vasc Surg 2002; 36: 250-5.
87. Mwipatayi BP, Bowles T, Balakrishnan S, Callaghan J, Haluszkiewicz E, Sieunarine K. Ischemic steal syndrome: a case series and review of current management. Curr Surg 2006; 63: 130-5.
88. Sottiurai VS, Lyon R, Ross C, Cooper M, Gonzales J. Surgical management of brachioaxillary-subclavian vein occlusion. Eur J Vasc Endovasc Surg 1996; 11: 225-9.
89. Vogel KM, Martino MA, O'Brien SP, Kerstein MD. Complications of lower extremity arteriovenous grafts in patients with end-stage renal disease. South Med J 2000; 93: 593-5.
90. NKF - K/DOQI Clinical Practice Guidelines for Vascular Access: update 2000. Am J Kidney Dis 2001; 37 (suppl): S137-81.
91. Munda R, First MR, Alexander JW, Linnemann CC Jr, Fidler JP, Kittur D. Polytetrafluoroethylene graft survival in hemodialysis. JAMA 1983; 249: 219-22.
92. Palder SB, Kirkman RL, Whittemore AD, Hakim RM, Lazarus JM, Tilney NL. Vascular access for hemodialysis. Patency rates and results of revision. Ann Surg 1985; 202: 235-9.
93. Schuman ES, Gross GF, Hayes JF, Standage BA. Long-term patency of polytetrafluoroethylene graft fistulas. Am J Surg 1988; 155: 644-6.
94. Bhandari S, Wilkinson A, Sellars L. Saphenous vein forearm grafts and goretex thigh grafts as alternative forms of vascular access. Clin Nephrol 1995; 44: 325-8.
95. Safa AA, Valji K, Roberts AC, Ziegler TW, Hye RJ, Oglevie SB. Detection and treatment of dysfunctional hemodialysis access grafts: effect of a surveillance program on graft patency and the incidence of thrombosis. Radiology 1996; 199: 653-7.
96. Miller PE, Carlton D, Deierhoi MH, Redden DT, Allon M. Natural history of arteriovenous grafts in hemodialysis patients. Am J Kidney Dis 2000; 36: 68-74.
97. Depner TA. Techniques for prospective detection of venous stenosis. Adv Ren Replace Ther 1994; 1: 119-30.
98. Martin LG, Macdonald MJ, Kikeri D, Cotsonis GA, Harker LA, Lumsden AB. Prophylactic angioplasty reduces thrombosis in virgin ePTFE arteriovenous dialysis grafts with greater than 50% stenosis: subset analysis of a prospectively randomised study. J Vasc Intervent Radiol 1999; 10: 389-96.
99. Cayco AV, Abu-Alfa AK, Mahnensmith RL, Perazella MA. Reduction in arteriovenous graft impairment: results of a vascular access surveillance protocol. Am J Kidney Dis 1998; 32: 302-8.
100. Sands JJ, Miranda CL. Prolongation of hemodialysis access survival with elective revision. Clin Nephrol 1995; 44: 329-33.
101. Owens ML, Stabile BE, Gahr JA, Wilson SE. Vascular grafts for haemodialysis: evaluation of sites and materials. Nephrol Dial Transplant 1979; 8: 521-30.